- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pfizer Inc (PFE)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.90
26.47
52 wk Range
20.92
27.69
PFE Comments
Compiled here, all relevant comments and discussions regarding the PFE stock. Please note that all comments included here have met Investing.com's Comment Guidelines.
never fails. always gives the gains back.
Pfizer is acquiring companies and licences here and there, expensive.
Impossible to overcome the 25-25 price point... 🫥
Dividend is reward for patience. Sell at $40-$45.
Is Board od directors looking at the price of this stock, how come they are not doing anything?!
I'm sure the CEO and his Executive Team got their huge annual bonuses. no growth until a change at the top.
Every day a bad news and CEO gets all that money, management needs to change I think stock is going to 24 I have 4000 shares stock here for 3 years The only think we have is Dividend If they cut Dividends we look at $20 stock
Another Down Grade for PFE The only thing we have is Dividend
Payout ratio losted at over 120%??! Is that sustainable?
The only thing we get from this stock is 7% Dividend Every day it gets some sort of bad news
Pfizer's PR isn't existent, practically. They don't "sell" good news to shareholders or press. So, press concentrates on every bit of bad news.
Very well said
When this mangent change we look at $29 stock
avis
long 25.5
I think price will be trending down to 23 as they lowered their guidance for 2026
disappointment again!😡
real value is about 40 per share
You are correct
Now 🚀🚀🚀
disappointed growth
another year of disappointmented growth
Looks like long term loading time
PFE at least positive at .70%. MRNA on fire at 13%.
This stock is great trading stock Between 24 to 27
I don't think much can go wrong with these prices...
very careful don't think he is pro-government cheap apple for 5 billion shares.... every day and from a trap. every day he does how he goes up and goes down more and more..... has he lost more than -3% this week? stay away they are deliberately dropping the stock
23,52 -23 target!!! ;)
I think you are being too optimistic with this target price. with this Leadership team including the CEO, I think end of year number will be lower than 23.00. Zero accountability.
George Galloway You may be right. I only calculated the chart. But it seems to be appropriate. Every day it pretends to go up and very quickly goes down.
absolute trap after all the rise.... good luck with the thieves.... it will break the lower resistance easily... only down
trap.....?
PFE used to be Darling of wall street Now its the worst stock last 3 years No matter what a good news come It goes down & Down Make me sick last 3 years
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.